Medical University of South Carolina
Charleston, SC
Accepting patients
LEADER Neoadjuvant Screening Trial: LCMC4 Evaluation of Actionable Drivers in Early Stage Lung Cancers
- Observational Trial
Accepting patients
ON-TRK
PrOspective Non-interventional Study in Patients With Locally Advanced or Metastatic TRK Fusion Cancer Treated With Larotrectinib
- Tyrosine Kinase (TK) Inhibitor